enGene Holdings Inc. (ENGN) vs Pyxis Oncology, Inc. (PYXS)
A side-by-side comparison of enGene Holdings Inc. and Pyxis Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENGN
enGene Holdings Inc.
$1.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PYXS
Pyxis Oncology, Inc.
$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ENGN vs PYXS
growth of $100 · dividends reinvested · last 3yENGN -90.7% (-54.6%/yr)PYXS +34.1% (+10.3%/yr)PYXS compounded faster over this window
Log scale — wide-divergence pair
ENGN PYXS
ENGN vs PYXS: by the numbers
- •PYXS is the larger company ($128M vs $121M market cap).
- •Both run net losses; ENGN's is the smaller (0.00% vs -803.83% net margin).
Metrics side by side
Valuation
| Metric | ENGN | PYXS |
|---|---|---|
| P/S ratio | N/A | 11.59 |
| P/B ratio | 0.52 | 11.19 |
Profitability
| Metric | ENGN | PYXS |
|---|---|---|
| Gross margin | 0.00% | 82.77% |
| Operating margin | 0.00% | -609.18% |
| Net margin | 0.00% | -803.83% |
| ROE | -2.13% | -775.59% |
| ROIC | -1.78% | -314.66% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.